Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,76%
1 114,14
+19,30
+1,76%
—1 094,841 107,911 119,421 107,91——
SIXC
Communications
SIXC
Communications
SIXC
+1,55%
613,60
+9,39
+1,55%
—604,21604,21614,73604,21——
SIXE
Energy
SIXE
Energy
SIXE
-4,09%
1 198,56
-51,15
-4,09%
—1 249,711 219,461 219,461 191,34——
SIXI
Industrials
SIXI
Industrials
SIXI
+2,60%
1 784,45
+45,19
+2,60%
—1 739,261 754,111 788,871 754,11——
SIXM
Financials
SIXM
Financials
SIXM
+0,50%
638,79
+3,16
+0,50%
—635,63637,46643,42637,46——
SIXR
Staples
SIXR
Staples
SIXR
+0,26%
850,50
+2,18
+0,26%
—848,32850,90853,05846,68——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1,35%
219,69
+2,93
+1,35%
—216,76216,76220,43216,76——
SIXT
Technology
SIXT
Technology
SIXT
+2,67%
3 424,19
+89,05
+2,67%
—3 335,143 376,133 425,523 360,29——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,45%
925,76
-13,58
-1,45%
—939,34937,32937,59924,48——
SIXV
Health care
SIXV
Health care
SIXV
+0,08%
1 469,40
+1,23
+0,08%
—1 468,171 468,981 476,501 464,14——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1,57%
2 424,62
+37,53
+1,57%
—2 387,092 394,182 436,802 394,18——
CRSP:NASDAQ
Crispr Therapeutics AG
USD 55,08
+5,15%
(+2,70) 1D
USD 54,80
-0,51% (-0,28)
After hours
Closed: 6 Mei, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRSP...
Open
USD 53,00
High
USD 55,40
Low
USD 52,65
Mkt. cap
5,31 mjd
Avg. vol.
1,70 m
Volume
2,53 m
52-wk high
USD 78,48
52-wk low
USD 33,50
EPS
-USD 6,21
Beta
1,27
Shares outstanding
96,45 m
No. of employees
393
News stories
From sources across the web
Profile
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
About Crispr Therapeutics AG
CEOSamarth Kulkarni
Employees393
Founded2013
HeadquartersZug, Zug, Switserland
Sector-
Websitecrisprtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
865,00 k
892,00 k
889,00 k
864,00 k
Cost of goods sold
129,99 m
115,05 m
116,02 m
137,23 m
Cost of revenue
129,99 m
115,05 m
116,02 m
137,23 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,30 m
18,92 m
16,93 m
18,40 m
Operating expense
19,30 m
18,92 m
16,93 m
18,40 m
Total operating expenses
149,29 m
133,96 m
132,95 m
155,63 m
Operating income
-148,42 m
-133,07 m
-132,06 m
-154,76 m
Other non operating income
13,54 m
22,07 m
26,24 m
24,76 m
EBT including unusual items
-134,89 m
-207,26 m
-105,82 m
-130,00 m
EBT excluding unusual items
-134,89 m
-111,00 m
-105,82 m
-130,00 m
Income tax expense
1,11 m
1,29 m
619,00 k
614,00 k
Effective tax rate
-0,82%
-0,62%
-0,58%
-0,47%
Other operating expenses
-
-
-
-
Net income
-136,00 m
-208,55 m
-106,44 m
-130,61 m
Net profit margin
-15 722,08%
-23 379,93%
-11 973,12%
-15 117,25%
Earnings per share
-1,58
-1,29
-1,17
-1,37
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-143,69 m
-128,42 m
-127,63 m
-149,10 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer